Study To Assess Adverse Events and Drug to Drug Interaction of Oral Tablet Atogepant and Ubrogepant in Adult Participants With a History of Migraine
Clinical trial NCT04818515 · COMPLETED
Trial details
- NCT number
- NCT04818515
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-17
- Primary completion
- 2021-06-18
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.